Regeneron Pharmaceuticals Stock Price - REGN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
After Hours
Last Trade
Last $ 356.37 ▼ -9.26 (-2.53%)
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -6.63 -1.78% 365.63 373.09 362.89 373.09 372.26 18:53:07
Bid Price Ask Price Spread Spread % News
356.02 356.71 0.69 0.19% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15,245 988,068 $ 366.23 $ 361,862,406 817,151 271.37 - 445.00
Last Trade Time Type Quantity Stock Price Currency
18:55:16 average 4,819 $ 365.63 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 40.14B 109.80M $ 2.44B 21.30 19.70 108.64M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 1.10%

more financials information »

Regeneron Pharmaceuticals News

Date Time Source News Article
12/09/201917:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
12/08/201909:00PR Newswire (US)First Clinical Data for REGN5458 (BCMAxCD3) Show Positive..
12/05/201909:40Dow Jones NewsRegeneron Reports Positive Phase 2 Data for Pozelimab in PNH
12/05/201907:00PR Newswire (US)Regeneron Announces Positive Topline Phase 2 Data with..
12/02/201916:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/27/201917:29Dow Jones NewsEarly Drug Treatment Sharply Reduces Deaths From Ebola
11/27/201917:00PR Newswire (US)New England Journal of Medicine Publishes Results of Ebola..

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week368.18373.73362.89369.07629,466-2.55-0.69%
1 Month340.34373.73337.03355.70763,83225.297.43%
3 Months285.555373.73271.37319.84730,57880.0828.04%
6 Months306.54373.73271.37310.02729,16959.0919.28%
1 Year374.52445.00271.37341.80742,706-8.89-2.37%
3 Years371.13543.5518271.37372.73803,809-5.50-1.48%
5 Years428.27605.9299271.37400.24794,346-62.64-14.63%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.
Your Recent History
NASDAQ
REGN
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191210 00:48:16